GCP
SRTA

GSA Capital Partners’s Strata Critical Medical Inc SRTA Stock Holding History

GSA Capital Partners’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$972K Buy
+184,470
New +$970K 0.06% 516
2025
Q2 		– Sell
-147,449
Closed -$403K – 1758
2025
Q1 		$403K Sell
147,449
-166,071
-53% -$596K 0.04% 947
2024
Q4 		$1.33M Sell
313,520
-64,720
-17% -$246K 0.1% 238
2024
Q3 		$1.11M Buy
378,240
+268,802
+246% +$856K 0.08% 409
2024
Q2 		$381K Sell
109,438
-174,286
-61% -$581K 0.03% 1137
2024
Q1 		$809K Buy
283,724
+119,410
+73% +$368K 0.06% 583
2023
Q4 		$580K Buy
+164,314
New +$472K 0.05% 695
2023
Q1 		– Sell
-53,226
Closed -$191K – 1498
2022
Q4 		$191K Buy
+53,226
New +$227K 0.02% 1196

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GSA Capital Partners's SRTA Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 184,470 shares worth $972K. The stake represents 0.06% of the portfolio and ranks #516 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in SRTA as recently as Q1 2025.

GSA Capital Partners first reported a position in SRTA in Q4 2022 and has held it in 8 quarters since. The position peaked at $1.33M in Q4 2024. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • GSA Capital Partners held 184,470 shares of Strata Critical Medical Inc worth $972K as of Q2 2026.
  • Strata Critical Medical Inc was a new GSA Capital Partners position in Q2 2026.
  • Strata Critical Medical Inc made up 0.06% of GSA Capital Partners's portfolio in Q2 2026, its #516 holding.
  • GSA Capital Partners first reported a position in Strata Critical Medical Inc in Q4 2022 and has held it in 8 quarters since.
  • GSA Capital Partners's Strata Critical Medical Inc position peaked at $1.33M in Q4 2024.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.